Hematology/Oncology News

In this video, Nisha Joseph, MD, an associate professor in the Department of Hematology and Medical Oncology at Emory University School of Medicine, discusses the new wave of novel therapeutics on the market to treat multiple myeloma.

Aerobic physical activity can reduce short- and long-term depression scores among adults with cancer, according to results of a systematic review and meta-analysis.

CHICAGO — In this Healio video exclusive, Brittne Halford, MD, MPH, and Altelisha Taylor, MD, MPH, both from Wealth Minded MD Podcast, discuss key tips on how to leverage debt for financial freedom at Women in Medicine Summit.

Cincinnati Children’s has retained its distinction as the No. 1 children’s hospital for cancer in the country.

Healio has announced the 2024 honorees of its peer-to-peer recognition program, Healio Honors.

BOSTON — Completing a CT scan and ordering lung cancer screening occurred more frequently if eligible patients received a digital health program intervention vs. enhanced usual care, according to data presented at the CHEST Annual Meeting.

The FDA has approved the supplemental new drug application for Ameluz topical gel 10% to increase the maximal dosage from one to three tubes per treatment of actinic keratosis, according to a Biofrontera press release.

A blood test for men at the time of a metastatic prostate cancer diagnosis may predict treatment response and survival, according to study results.

A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.

Adults with Graves’ disease treated with antithyroid drugs have a higher risk for multiple types of cancer compared with the general population, according to findings published in Thyroid.